The British drug maker GlaxoSmithKline said late Tuesday that the Serious Fraud Office of Britain had opened a formal criminal investigation into its “commercial practices.” Neither GlaxoSmithKline nor the fraud office provided further details about what practices were being investigated. . …read more
